Linda: Top 10 drugs in 2029
Linda: New targets without anybody in clinical or marketed
Kristine: Rare disease deals
Trevor: VCs waiting for wreckage to settle
Linda: Sanofi- a snapshot
Linda: A small analysis of license amendments
Kristine: Licensing deal trends
Trevor: Market Sentiment: Up or Down?
Linda: Boehringer Ingelheim snapshot
Linda: China: economy and deals
Kristine: The impact of the US Inflation Reduction Act
Trevor: Market Sentiment: Not Easy
Linda: Deal terminations in 2023
Linda: Why deals fail to get signed? What to do?
Kristine: GPCRs
Trevor: Bio Focus and Raises in Oncology
Linda: Protacs - an update
Linda: Talking to the right person?
Kristine: Cell & Gene Therapy Landscape
Trevor: Market Sentiment: Frozen